Synjardy is a prescription medication used to manage blood sugar levels in adults with type 2 diabetes. It is a combination of two active ingredients: empagliflozin and metformin. Empagliflozin works by helping the kidneys remove glucose from the bloodstream through the urine, while metformin decreases glucose production in the liver and improves the body's sensitivity to insulin. This dual mechanism of action makes Synjardy effective in lowering blood sugar levels, which can help prevent the long-term complications of diabetes. It is typically prescribed alongside diet and exercise to achieve optimal blood sugar control. However, it is not suitable for treating type 1 diabetes or diabetic ketoacidosis. Patients should discuss their medical history and potential side effects with their healthcare provider before starting Synjardy.